Results 111 to 120 of about 609,392 (314)

Anne-Marie Houdebine par elle-même. Entretien avec Sylvia Duverger

open access: yesGlad!
This interview, first published in the columns of BibliObs in 2016, outlines a genealogy of the work of the linguist and psychoanalyst Anne-Marie Houdebine-Gravaud, a specialist in linguistic imaginaries and sexism in language.The interview takes the ...
Anne-Marie Houdebine, Sylvia Duverger
doaj   +1 more source

Patient‐specific pharmacogenomics demonstrates xCT as predictive therapeutic target in colon cancer with possible implications in tumor connectivity

open access: yesMolecular Oncology, EarlyView.
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker   +16 more
wiley   +1 more source

Violence sexuelle et de genre à l’université : du secret à la bataille pour la reconnaissance

open access: yesBrésil(s), 2019
This article, from the point of view of a professor, discusses the cases of sexual and gender violence that were published in the press and became the subject of a Parliamentary Commission of Inquiry (CPI) in 2015 in the state of São Paulo.
Heloisa Buarque de Almeida
doaj  

Discourse, Antagonisms, and Identities during the COVID-19 Pandemic

open access: yesRevista Crítica de Ciências Sociais, 2022
This study utilizes theory from the Essex School of Ideology and Discourse Analysis (IDA) and investigates speeches and statements made by high-ranking European Union officials from the European Commission as well as policy documents. The inquiry reveals
Alexei Anisin
doaj  

Predictors of response and rational combinations for the novel MCL‐1 inhibitor MIK665 in acute myeloid leukemia

open access: yesMolecular Oncology, EarlyView.
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad   +17 more
wiley   +1 more source

571 A catalyst for change: Elevating mental health considerations in Ontario using a mental health in all policies approach

open access: yesJournal of Clinical and Translational Science
Objectives/Goals: Our goal for this project is to develop a metric that integrates the intersectional social and structural determinants of health and well-being into the existing policy development framework to impact the integration of such ...
Tala Lumbu   +5 more
doaj   +1 more source

Aggressive prostate cancer is associated with pericyte dysfunction

open access: yesMolecular Oncology, EarlyView.
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero   +11 more
wiley   +1 more source

Tapol bulletin no, 108, December 1991 [PDF]

open access: yes, 1991
Contents: Bishop Belo on the massacre -- Worldwide condemnation -- Massacre among the graves by Max Stahl -- ABRI chief: "They must be wiped out" -- The death and life of Kamal Bamadhaj -- Extracts from Kamal's diary -- Suharto's inquiry commission a ...

core  

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

open access: yesMolecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang   +8 more
wiley   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy